FDA Adverse Event Injury Summary report: N

CONTINUUM LONGEVITY CROSSLINKED POLY LINER

MDR report key: 2051055 · Received April 5, 2011

Report

Report Number
1822565-2011-00853
Event Type
Injury
Date Received
April 5, 2011
Date of Event
December 20, 2010
Report Date
March 8, 2011
Manufacturer
ZIMMER INC
Product Code
JDI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: SURGICAL NOTES WERE NOT PROVIDED. X-RAYS WERE NOT PROVIDED; IT IS UNK WHETHER THE COMPONENTS WERE IMPLANTED WITH THE CORRECT FIT AND ORIENTATION AS PER THE SURGICAL TECHNIQUE. DISLOCATION CAN BE ASSOCIATED WITH A NUMBER OF MECHANISMS. UNSATISFACTORY PLACEMENT OF THE COMPONENT PARTS. EXTENT OF COMPONENT STABILITY. IF COMPONENTS THAT WERE NOT MATCHED FOR THE PT REQUIREMENTS ARE USED, THIS MAY INCREASE THE INSTABILITY OF THE JOINT. EXTENT OF SOFT TISSUE TENSION. INADEQUATE SOFT TISSUE TENSION AND/OR POOR FUNCTIONAL MUSCLES AROUND THE HIP MAY NOT BE ABLE TO PROVIDE FUNCTIONAL SUPPORT TO THE JOINT. PT BEHAVIOR. THERE IS INSUFFICIENT INFO TO PERFORM A PROBABLE CAUSE ANALYSIS. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED WITH THE INFO PROVIDED. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT FIND ANY DEVIATIONS OR ANOMALIES. IT IS NOT SUSPECTED THAT THE PRODUCT FAILED TO MEET SPECIFICATIONS. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFO BE RECEIVED, THE COMPLAINT WILL BE REOPENED. ZIMMER, INC., CONSIDERS THE INVESTIGATION CLOSED.

Description of Event or Problem · 1

IT IS REPORTED THAT THE PT PRESENTED FOR SECOND DISLOCATION FOLLOWING PRIMARY SURGERY. DISLOCATION WAS REPLACED THROUGH A CLOSED REDUCTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CONTINUUM LONGEVITY CROSSLINKED POLY LINER JDI ZIMMER INC 61365990

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention